Preoperative Cisplatin in Early Stage Breast Cancer
NCT00148694
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
27
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Cisplatin
Sponsor
Dana-Farber Cancer Institute
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]